Inventor · disambiguated record
William W. Hauswirth
Also filed as: HAUSWIRTH WILLIAM · HAUSWIRTH WILLIAM H · HAUSWIRTH WILLIAM S · HAUSWIRTH WILLIAM W
26 granted patents·27 pending applications·1,350 citations·filing 1996–2025
97Inventor score
Top patents by PatentIndex Score
53 records- 0198US5874304AHumanized green fluorescent protein genes and methodsUNIV FLORIDA·Filed 1996·Granted Feb 23, 1999·585 cites·81 claims
- 0297US5968750AHumanized green fluorescent protein genes and methodsUNIV FLORIDA·Filed 1998·Granted Oct 19, 1999·173 cites·30 claims
- 0396US10426844B2Capsid-mutated rAAV vectors and methods of useUNIV FLORIDA·Filed 2016·Granted Oct 1, 2019·24 cites·10 claims
- 0495US7094604B2Production of pseudotyped recombinant AAV virionsUNIV FLORIDA·Filed 2004·Granted Aug 22, 2006·214 cites·35 claims
- 0594US6020192AHumanized green fluorescent protein genes and methodsUNIV FLORIDA·Filed 1997·Granted Feb 1, 2000·167 cites·11 claims
- 0693US11325956B2Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2019·Granted May 10, 2022·7 cites·11 claims
- 0792US8298818B2Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoterBOYE SANFORD LEON·Filed 2007·Granted Oct 30, 2012·37 cites·11 claims
- 0892US8147823B2Method of treating or retarding the development of blindnessACLAND GREGORY M·Filed 2010·Granted Apr 3, 2012·24 cites·8 claims
- 0990US10648000B2rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetesUNIV FLORIDA·Filed 2016·Granted May 12, 2020·9 cites·13 claims
- 1090US10214572B2Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2014·Granted Feb 26, 2019·16 cites·7 claims
- 1189US12188041B2Codon optimized otoferlin AAV dual vector gene therapyUNIV FLORIDA·Filed 2019·Granted Jan 7, 2025·4 cites·7 claims
- 1288US11160488B2Reagents and methods for modulating cone photoreceptor activityUNIV WASHINGTON·Filed 2018·Granted Nov 2, 2021·2 cites·5 claims
- 1385US9770491B2AAV-mediated gene therapy for RPGR X-linked retinal degenerationUNIV PENNSYLVANIA·Filed 2013·Granted Sep 26, 2017·9 cites·12 claims
- 1485US9433688B2Method of treating or retarding the development of blindnessUNIV PENNSYLVANIA·Filed 2014·Granted Sep 6, 2016·2 cites·17 claims
- 1585US7342111B2Adeno-associated virus-delivered ribozyme compositions and methods of useUNIV FLORIDA·Filed 2005·Granted Mar 11, 2008·11 cites·16 claims
- 1683US9198595B2Reagents and methods for modulating cone photoreceptor activityNEITZ JAY·Filed 2013·Granted Dec 1, 2015·12 cites·12 claims
- 1780US12390146B2Reagents and methods for modulating cone photoreceptor activityUNIV FLORIDA·Filed 2021·Granted Aug 19, 2025·0 cites·10 claims
- 1880US10383922B2AAV-mediated gene therapy for RPGR X-linked retinal degenerationUNIV PENNSYLVANIA·Filed 2017·Granted Aug 20, 2019·3 cites·12 claims
- 1979US6225291B1Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseasesUNIV FLORIDA·Filed 1998·Granted May 1, 2001·45 cites·62 claims
- 2077US2025215437A1Compositions and methods for treatment of dominant retinitis pigmentosaUNIV FLORIDA·Filed 2024·Application pending·0 cites
- 2175US11118185B2AAV vectors for treatment of dominant retinitis pigmentosaUNIV FLORIDA·Filed 2017·Granted Sep 14, 2021·1 cites·34 claims
- 2274US2009074723A1Method of Treating or Retarding the Development of BlindnessUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 2373US2022186260A1Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)UNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2473US2023103708A1Methods for treating eye diseaseMUSC FOUND FOR RES DEV·Filed 2022·Application pending·0 cites
- 2572US9375491B2Chimeric promoter for cone photoreceptor targeted gene therapyUNIV FLORIDA·Filed 2012·Granted Jun 28, 2016·1 cites·5 claims
- 2670US11512326B2Small angiotensin peptide expression system in mammalian cellsLI QIUHONG·Filed 2010·Granted Nov 29, 2022·2 cites·11 claims
- 2769US9816108B2rAAV-guanylate cyclase compositions and methods for treating lebers congenital amaurosis-1 (LCA1)BOYE SHANNON ELIZABETH·Filed 2011·Granted Nov 14, 2017·2 cites·7 claims
- 2868US12203074B2Compositions and methods for treatment of dominant retinitis pigmentosaUNIV FLORIDA·Filed 2019·Granted Jan 21, 2025·0 cites·20 claims
- 2968US2025367325A1Compositions and methods for expressing otoferlinUNIV FLORIDA·Filed 2025·Application pending·0 cites
- 3067US2013216500A1Method of treating or retarding the development of blindnessUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 3167US2025243509A1Methods for treating eye diseaseMUSC FOUND FOR RES DEV·Filed 2025·Application pending·0 cites
- 3265US2021130421A1Dual-aav vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 3364US2016263246A1Method of Treating or Retarding the Development of BlindnessUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3463US2021324387A1Aav vectors for treatment of dominant retinitis pigmentosaUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3562US2019343920A1Aav-mediated gene therapy for nphp5 lca-ciliopathyUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 3662US2012225930A1Method of treating or retarding the development of blindnessACLAND GREGORY M·Filed 2012·Application pending·0 cites
- 3762US2007077228A1Method of treating or retarding the development of blindnessCORNELL RES FOUNDATION INC·Filed 2006·Application pending·0 cites
- 3860US2012093772A1Vectors for delivery of light sensitive proteins and methods of useHORSAGER ALAN·Filed 2009·Application pending·0 cites
- 3955US12359221B2Compositions and methods for expressing otoferlinUNIV FLORIDA·Filed 2018·Granted Jul 15, 2025·0 cites·9 claims
- 4054US2017348387A1Aav-mediated gene therapy for nphp5 lca-ciliopathyUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 4154US2018100165A1Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)UNIV FLORIDA·Filed 2017·Application pending·0 cites
- 4254US2016015288A1Reagents and methods for modulating cone photoreceptor activityNEITZ JAY·Filed 2015·Application pending·0 cites
- 4352US2007015238A1Production of pseudotyped recombinant AAV virionsSNYDER RICHARD O·Filed 2003·Application pending·0 cites
- 4451US2003224485A1Expression system for ABC transportersFiled 2003·Application pending·0 cites
- 4551US2022033826A1Adeno-associated viral vectors for the treatment of best diseaseUNIV FLORIDA·Filed 2019·Application pending·0 cites
- 4650US2015225741A1Vectors for delivery of light sensitive proteins and methods of useEOS NEUROSCIENCE INC·Filed 2014·Application pending·0 cites
- 4750US2022347318A1Methods and compositions for the expression of constitutively active rap1a from a vmd2 promoterUNIV UTAH RES FOUND·Filed 2020·Application pending·0 cites
- 4849US2006193830A1Raav vector compositions and methods for the treatment of choroidal neovascularizationHAUSWIRTH WILLIAM W·Filed 2003·Application pending·0 cites
- 4949US2003129164A1Expression of glial-derived neurotrophic factor for treatment of diseases of the eyeFiled 2002·Application pending·0 cites
- 5045US2006127358A1Raav expression systems and methods for enhancing transduction of mammalian neural cellsMUZYCZKA NICHOLAS·Filed 2003·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William W. Hauswirth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →